INMB - INmune Bio GAAP EPS of -$0.48 misses by $0.09
2023-11-01 16:57:03 ET
More on INmune Bio
- Capitalizing On Inflammation's Role In Neurological Disease Part 2: INmune Bio
- INmune Bio: Some Promise, But Take Care Here
- INmune Bio, Inc. (INMB) Q2 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on INmune Bio
- Historical earnings data for INmune Bio
For further details see:
INmune Bio GAAP EPS of -$0.48 misses by $0.09